FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078149441> ?p ?o ?g. }

• W2078149441 endingPage "269" @default.
• W2078149441 startingPage "263" @default.
• W2078149441 abstract "To investigate the activation of the AKT and mammalian target of rapamycin (mTOR) pathways and assess the inhibitory effects of rapamycin on those pathways in canine malignant melanoma cells.3 established primary canine melanoma cell lines generated from naturally occurring tumors.Expressions of total and phosphorylated AKT, mTOR, and p70 ribosomal S6 kinase 1 (p70S6K) in canine melanoma cells that were or were not exposed to 10nM rapamycin were assessed via western blot analysis. Clonogenic assays were performed to determine the surviving fraction of melanoma cells after exposure to 0.1, 1, 10, or 100nM rapamycin.Expressions of total and phosphorylated AKT, mTOR, and p70S6K proteins were detected (ie, the AKT and mTOR pathways were activated) in all 3 cell lines. Rapamycin treatment resulted in decreases in phosphorylated mTOR expression and phosphorylated p70S6K expression but no change in phosphorylated AKT expression. Expression of total AKT, mTOR, and p70S6K persisted after rapamycin treatment. There was a significant dose-dependent decrease in surviving tumor cell fraction for each cell line following treatment with rapamycin.These data indicated that AKT and mTOR, as well as their downstream product p70S6K, are present and active in canine melanoma cells. Activation of the mTOR pathway can be inhibited by rapamycin; treatment of melanoma cells with rapamycin decreased the surviving tumor cell fraction. Use of mTOR inhibitors as antineoplastic treatments in dogs with melanoma warrants investigation. Furthermore, these data support the use of canine melanoma cells as a molecular model for melanoma in humans." @default.
• W2078149441 created "2016-06-24" @default.
• W2078149441 creator A5004921008 @default.
• W2078149441 creator A5035837602 @default.
• W2078149441 creator A5040502320 @default.
• W2078149441 date "2009-02-01" @default.
• W2078149441 modified "2023-10-16" @default.
• W2078149441 title "Activation of the AKT and mammalian target of rapamycin pathways and the inhibitory effects of rapamycin on those pathways in canine malignant melanoma cell lines" @default.
• W2078149441 cites W1966133006 @default.
• W2078149441 cites W1969615014 @default.
• W2078149441 cites W1969886925 @default.
• W2078149441 cites W1984809836 @default.
• W2078149441 cites W1988620734 @default.
• W2078149441 cites W1997228516 @default.
• W2078149441 cites W2007443131 @default.
• W2078149441 cites W2008932991 @default.
• W2078149441 cites W2009685421 @default.
• W2078149441 cites W2013453542 @default.
• W2078149441 cites W2028920064 @default.
• W2078149441 cites W2028994134 @default.
• W2078149441 cites W2031701557 @default.
• W2078149441 cites W2032911082 @default.
• W2078149441 cites W2035029345 @default.
• W2078149441 cites W2035708291 @default.
• W2078149441 cites W2036108147 @default.
• W2078149441 cites W2067572360 @default.
• W2078149441 cites W2070119291 @default.
• W2078149441 cites W2081620539 @default.
• W2078149441 cites W2082055753 @default.
• W2078149441 cites W2088363975 @default.
• W2078149441 cites W2111135080 @default.
• W2078149441 cites W2113365503 @default.
• W2078149441 cites W2115820946 @default.
• W2078149441 cites W2126493366 @default.
• W2078149441 cites W2157274263 @default.
• W2078149441 cites W2163382569 @default.
• W2078149441 cites W2166263504 @default.
• W2078149441 cites W4255873082 @default.
• W2078149441 cites W4327494035 @default.
• W2078149441 doi "https://doi.org/10.2460/ajvr.70.2.263" @default.
• W2078149441 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4169881" @default.
• W2078149441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19231960" @default.
• W2078149441 hasPublicationYear "2009" @default.
• W2078149441 type Work @default.
• W2078149441 sameAs 2078149441 @default.
• W2078149441 citedByCount "29" @default.
• W2078149441 countsByYear W20781494412012 @default.
• W2078149441 countsByYear W20781494412013 @default.
• W2078149441 countsByYear W20781494412014 @default.
• W2078149441 countsByYear W20781494412015 @default.
• W2078149441 countsByYear W20781494412016 @default.
• W2078149441 countsByYear W20781494412017 @default.
• W2078149441 countsByYear W20781494412018 @default.
• W2078149441 countsByYear W20781494412019 @default.
• W2078149441 countsByYear W20781494412020 @default.
• W2078149441 countsByYear W20781494412021 @default.
• W2078149441 countsByYear W20781494412022 @default.
• W2078149441 countsByYear W20781494412023 @default.
• W2078149441 crossrefType "journal-article" @default.
• W2078149441 hasAuthorship W2078149441A5004921008 @default.
• W2078149441 hasAuthorship W2078149441A5035837602 @default.
• W2078149441 hasAuthorship W2078149441A5040502320 @default.
• W2078149441 hasBestOaLocation W20781494411 @default.
• W2078149441 hasConcept C104202773 @default.
• W2078149441 hasConcept C117262875 @default.
• W2078149441 hasConcept C11960822 @default.
• W2078149441 hasConcept C1491633281 @default.
• W2078149441 hasConcept C185592680 @default.
• W2078149441 hasConcept C2777658100 @default.
• W2078149441 hasConcept C2780926556 @default.
• W2078149441 hasConcept C43060935 @default.
• W2078149441 hasConcept C502942594 @default.
• W2078149441 hasConcept C54355233 @default.
• W2078149441 hasConcept C55493867 @default.
• W2078149441 hasConcept C62112901 @default.
• W2078149441 hasConcept C62478195 @default.
• W2078149441 hasConcept C75217442 @default.
• W2078149441 hasConcept C81885089 @default.
• W2078149441 hasConcept C86554907 @default.
• W2078149441 hasConcept C86803240 @default.
• W2078149441 hasConcept C95444343 @default.
• W2078149441 hasConcept C98490376 @default.
• W2078149441 hasConceptScore W2078149441C104202773 @default.
• W2078149441 hasConceptScore W2078149441C117262875 @default.
• W2078149441 hasConceptScore W2078149441C11960822 @default.
• W2078149441 hasConceptScore W2078149441C1491633281 @default.
• W2078149441 hasConceptScore W2078149441C185592680 @default.
• W2078149441 hasConceptScore W2078149441C2777658100 @default.
• W2078149441 hasConceptScore W2078149441C2780926556 @default.
• W2078149441 hasConceptScore W2078149441C43060935 @default.
• W2078149441 hasConceptScore W2078149441C502942594 @default.
• W2078149441 hasConceptScore W2078149441C54355233 @default.
• W2078149441 hasConceptScore W2078149441C55493867 @default.
• W2078149441 hasConceptScore W2078149441C62112901 @default.
• W2078149441 hasConceptScore W2078149441C62478195 @default.
• W2078149441 hasConceptScore W2078149441C75217442 @default.
• W2078149441 hasConceptScore W2078149441C81885089 @default.
• W2078149441 hasConceptScore W2078149441C86554907 @default.

• next